Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver failure caused by flutamide]

P L Guzmán Martínez-Valls1, R Ferrero Doria, J P Morga Egea

  • 1Servicio de Urología, Hospital General Universitario de Murcia.

Actas Urologicas Espanolas
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laparoscopic latero-abdominal colposuspension: Description of the technique, advantages and preliminary results.

Actas urologicas espanolas·2020
Same author

[Inverted papilloma of the bladder with recurrence in prostatic urethra].

Actas urologicas espanolas·2006
Same author

[Malignant retroperitoneal schwannoma].

Actas urologicas espanolas·2005
Same author

[Inverted papilloma of the upper urinary tract].

Actas urologicas espanolas·2005
Same author

[Ureteral obstruction secondary to Rosai-Dorfman disease].

Actas urologicas espanolas·2005
Same author

[Calcified retroperitoneal liposarcoma].

Actas urologicas espanolas·2004
Same journal

Comparative outcomes of Mini-PCNL and suction-assisted flexible ureteroscopy in patients with renal stones ≥2 cm.

Actas urologicas espanolas·2026
Same journal

Morphometric changes in pelvic floor structure following non-invasive rehabilitation and neuromodulation assessed by ultrasound imaging.

Actas urologicas espanolas·2026
Same journal

Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.

Actas urologicas espanolas·2026
Same journal

i-PCNL: a novel ureteral-catheter application for continuous unidirectional high-flow irrigation during Percutaneous Nephrolithotomy. Technique description and preliminary outcomes.

Actas urologicas espanolas·2026
Same journal

Reconstructing the reconstructed: Outcomes of redo-urethroplasty for recurrent urethral strictures.

Actas urologicas espanolas·2026
Same journal

Functional outcomes of pyeloplasty in children with reduced preoperative renal function: A multicenter study.

Actas urologicas espanolas·2026
See all related articles

Flutamide, used for prostate cancer, can cause severe liver damage (hepatotoxicity), despite its low reported incidence. Close patient monitoring and prompt drug withdrawal are crucial to prevent potentially fatal liver failure.

Area of Science:

  • Hepatology
  • Oncology
  • Pharmacology

Background:

  • Flutamide is a non-steroidal anti-androgen prescribed for prostate cancer, often with LHRH-analogs.
  • While literature suggests a low incidence (≤0.18%) of Flutamide-induced hepatotoxicity, FDA reports indicate significant adverse events, including fatalities and hospitalizations.

Observation:

  • Two cases of prostate adenocarcinoma patients treated with Flutamide and LHRH-analogs developed liver failure.
  • One patient experienced acute hepatitis, recovering after Flutamide discontinuation.
  • The second patient progressed to micronodular cirrhosis, succumbing to decompensated liver failure and hepatorenal syndrome.

Findings:

  • This study presents two severe cases of Flutamide-induced liver failure in prostate cancer patients.

Related Experiment Videos

  • A literature review explores potential biological mechanisms behind Flutamide's liver toxicity.
  • The findings highlight a higher risk than previously suggested by incidence rates.

    • Implications:

    • Clinical and laboratory monitoring of patients undergoing Flutamide treatment is essential.
    • Promptly recognizing and acting on symptoms of hepatic dysfunction is imperative.
    • Early drug withdrawal can mitigate the risk of severe, potentially fatal, liver injury.